The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Networks of state officials, advocates, and others aiming to invest in and transform primary care.
A program dedicated to advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders’ ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources offer relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
July 29, 2026
Quarterly Article
Sarah B. Windle
Peter M. Socha
Jasleen Arneja
Sam Harper
Genevieve Gore
Geneviéve Gariépy
Eva Graham
Andrea Benedetti
Arijit Nandi
Sep 14, 2026
June 2026
Mental Health and Substance Use Challenges
Back to The Milbank Quarterly
Policy Points:
Context: Substantial changes in cannabis policies are occurring globally; however, the impacts of these reforms on cannabis use, as well as downstream effects on other substance use, remain unclear.
Methods: We conducted a systematic review to identify studies examining the impact of a cannabis policy change on substance use. We searched Embase, Medline, PsycINFO, the Web of Science Core Collection, and the Criminal Justice Database, as well as gray literature sources including the Social Science Research Network. The included studies employed a quasi-experimental approach and were assessed for risk of bias using a modified version of ROBINS-I to facilitate the assessment of these designs. The findings were synthesized using a descriptive, analytical approach.
Findings: The included reports (N = 176) were published between 1993 and 2024, with approximately two-thirds published after 2019. Most were peer-reviewed publications (n = 148) applying a difference-in-differences (n = 129) or interrupted time series (n = 42) approach to data from the United States (n = 141). Medical and recreational cannabis legalization may increase cannabis initiation across age groups, with increased prevalence of cannabis use among young adults and adults and inconsistent evidence among youth. The impacts on alcohol use were differential by policy and age group, with potential decreases following medical legalization and potential increases following recreational legalization among young adults. Evidence from a limited number of studies suggested potential decreases in tobacco use among all age groups. Most studies found no change or a decrease in opioid-related outcomes, although evidence was less consistent for opioid-related mortality. We found few studies examining cannabis decriminalization, with no clear evidence of changes in cannabis or other substance use.
Conclusions: Overall, these findings suggest that medical and recreational legalization increase cannabis use, with weaker effects among youth. In addition, potential substitution effects were identified for other substances (e.g., alcohol, tobacco, opioids), excepting complementary alcohol use among young adults following recreational cannabis legalization.